Deferoxamine

transferrin ; Homo sapiens







55 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34439518 Targeting Pro-Oxidant Iron with Deferoxamine as a Treatment for Ischemic Stroke: Safety and Optimal Dose Selection in a Randomized Clinical Trial. 2021 Aug 10 1
2 24511682 [Critical conditions as a logical and appropriate series of events in iron methabolism disorders (the summary of experimental studies)]. 2013 Nov-Dec 1
3 23001181 Annotating MYC status with 89Zr-transferrin imaging. 2012 Oct 2
4 20627190 Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone. 2010 Aug 1
5 17919118 Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy. 2008 Jan 15 1
6 15993339 Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin. 2005 Aug 1 2
7 16339661 Recent insights into interactions of deferoxamine with cellular and plasma iron pools: Implications for clinical use. 2005 1
8 11888669 Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells. 2002 May 28 1
9 12529982 Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo. 2002 Sep-Oct 1
10 11157499 Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy. 2001 Feb 1 2
11 11389698 Effect of iron deficiency on placental transfer of iron and expression of iron transport proteins in vivo and in vitro. 2001 Jun 15 1
12 30147567 Transferrin Ensures Survival of Ovarian Carcinoma Cells Subjected to Deferoxamine, TNFA, FASL, Trail or MYC-Activation. 2001 1
13 11099901 Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapy. 2000 Dec 1
14 17312669 Myocardial release of non-transferrin-bound iron during cardio-pulmonary bypass surgery. 1999 1
15 17312675 Removal of non-transferrin-bound iron from blood with iron overload using a device with immobilized desferrioxamine. 1999 2
16 9350180 Iron chelation therapy. 1997 1
17 8695819 Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. 1996 Jul 15 1
18 8764564 In vitro tumor growth inhibition by bispecific antibodies to human transferrin receptor and tumor-associated antigens is augmented by the iron chelator deferoxamine. 1996 Aug 1
19 8767477 Hepatic uptake of iron by receptor-mediated and receptor-independent mechanisms. 1996 Jun 2
20 8808120 Influence of iron status in the response to the deferoxamine test. 1996 Jan 1
21 7492790 The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents. 1995 Dec 1 1
22 7890311 Lymphocyte lines under iron-depriving conditions: transferrin receptor expression related to various growth responses. 1994 Oct 2
23 7964124 The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis. 1994 Nov 2
24 7975362 [Treatment of iron overload states with oral administration of the chelator agent, L1 (Deferiprone)]. 1994 Sep 1
25 8129715 Iterative endocytosis of transferrin by K562 cells. 1994 Feb 15 1
26 8163646 Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. 1994 Apr 2
27 8306330 The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell. 1994 Feb 1 3
28 8348983 Inhibition of growth of the lymphocyte lines by deferoxamine under various iron-supply conditions. 1993 1
29 8358725 Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle. 1993 Sep 1 1
30 8439591 The in vitro response of human tumour cells to desferrioxamine is growth medium dependent. 1993 Jan 1
31 8450906 Direct effect of deferoxamine on hemoglobin synthesis in patients on hemodialysis treated with recombinant human erythropoietin. 1993 1
32 1543713 The effect of desferrioxamine and ferric ammonium citrate on the uptake of iron by the membrane iron-binding component of human melanoma cells. 1992 Jan 31 1
33 1591866 Aluminum-binding serum proteins: desferrioxamine alters serum aluminum speciation. 1992 Apr 30 1
34 2228020 Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine. 1990 Oct 2
35 2349215 Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. 1990 Jun 1
36 2383920 High performance liquid chromatography methods for studying protein binding of aluminium in human serum in the absence and in the presence of desferrioxamine. 1990 Jul 1
37 3162307 Two genetic loci participate in the regulation by iron of the gene for the human transferrin receptor. 1988 Mar 1
38 3171105 Lymphocyte activation, iron uptake and release by human mononuclear leukocytes in the presence of desferrioxamine. 1988 1
39 3196300 Chelation of transferrin iron by desferrioxamine in K562 cells. The partition of iron between ferrioxamine and ferritin. 1988 Sep 15 5
40 3198619 Ferritin iron kinetics and protein turnover in K562 cells. 1988 Dec 15 1
41 3608980 Noncoding 3' sequences of the transferrin receptor gene are required for mRNA regulation by iron. 1987 May 1
42 3699915 Affinity of the aluminium binding protein. 1986 Mar 2
43 3785148 Transcriptional regulation by iron of the gene for the transferrin receptor. 1986 Jan 1
44 3790074 The effect of desferrioxamine on transferrin receptors, the cell cycle and growth rates of human leukaemic cells. 1986 May 15 3
45 2985960 Effects of alterations in cellular iron on biosynthesis of the transferrin receptor in K562 cells. 1985 Apr 3
46 2987233 Iron metabolism in K562 erythroleukemic cells. 1985 Jun 10 1
47 2995450 Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells. 1985 Sep 1
48 6092356 Effect of iron chelators on the transferrin receptor in K562 cells. 1984 Nov 10 1
49 6092369 Heme regulation of HeLa cell transferrin receptor number. 1984 Nov 10 1
50 6142046 Biosynthetic regulation of the human transferrin receptor by desferrioxamine in K562 cells. 1984 Mar 10 3